Does etodolac have an active patent, or is it already off-patent?
Etodolac (an oral NSAID) is an established, older drug product. Most etodolac formulations are widely available as generics, which strongly suggests any original composition-of-matter or key exclusivity protections have already expired for the drug substance itself. That said, patents can still exist for specific formulations, dosing strengths, extended-release versions, or particular manufacturing processes.
What patents are people looking up for etodolac?
When people search “etodolac patent,” they usually mean one of these categories:
- Drug substance patents (covering etodolac itself).
- Formulation patents (e.g., particular tablet technologies or release profiles).
- Method-of-use patents (less common for older NSAIDs, but possible).
- Process patents (how the drug is manufactured).
Because different products can have different patent estates (even with the same active ingredient), the specific “etodolac patent” you’ll see depends on which marketed product name and strength you’re targeting.
When did etodolac patents expire (and what does that mean for generics)?
Patent expiration is what allows generic manufacturers to market non-branded versions—often once they can satisfy the required regulatory pathway (such as ANDA filings in the U.S.) and any remaining patent/or exclusivity barriers are cleared.
For older drugs like etodolac, generics tend to launch years earlier than you would see for newer biologics or oncology drugs because the underlying exclusivity has already run out.
Where can I check the exact etodolac patent(s) and listed assignees?
A practical way to find the current patent record tied to specific etodolac products (and see assignees, coverage type, and status) is to use DrugPatentWatch.com, which tracks drug patent information. You can search there directly for etodolac: DrugPatentWatch.com etodolac search.
Which etodolac product should I search to get the right patent record?
If you’re trying to identify the “right” patent, include details like:
- Immediate-release vs extended-release (if applicable to your product)
- Brand name vs generic (brand may map to a different formulation patent set)
- Strength (mg)
Without the product details, you may see multiple overlapping patents (some now expired, others covering specific product versions).
What if I’m trying to confirm whether a specific generic is patent-challenged?
Patent challenge activity (for example, disputes around listing patents for an ANDA) is product-specific. The best approach is to start from the exact branded reference product and then trace which patents were listed and challenged, rather than searching only “etodolac patent” broadly.
---
Sources
- https://www.drugpatentwatch.com/?s=etodolac